Company Overview

Update
Headquarters:
San Diego, CA
Funding:
$9M
Categories:
Biotechnology

Tragara is focused on the clinical and commercial development of patented drugs for the treatment of various cancers.

Description

Update

Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of various cancers. Tragara launched operations in January 2007 and is focusing its development resources on two proprietary compounds: (1) Capoxigem® (apricoxib; TG01), an oral, potent, and selective inhibitor of cyclooxygenase-2 (COX-2) for the treatment of solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer and (2) TG02- multikinase inhibitor for the treatment of hematologic and solid tumors.

Board Members and Advisors (2)

Update

Investments (1)

Update
  • 77b7aa05475b5989c19a3cd7fb739913

    S*Bio

    S*BIO focused on the discovery and clinical development of targeted drugs for the treatment of..

    $112.50M  / Private Equitywith 1 other investors

    Jan 21, 2009 - Funding Round

Funding Rounds (2) - $9M

Update

Investors (5)

Update

Offices/Locations (1)

Update
  • HQ

    10955 Vista Sorrento Parkway, Suite 120

    San Diego, CA 92130

    USA

Images (1)

Update
  • F8a94d5f65d22a628631a9331819bbf4